Literature DB >> 17162224

Reversal of fibrosis: no longer a pipe dream?

Jonathan A Fallowfield1, Timothy J Kendall, John P Iredale.   

Abstract

The reversal of liver fibrosis is not a new phenomenon. Treatment of the primary disease remains the most effective strategy, but new approaches to promote resolution of fibrosis are being built on the foundations that were provided by research into the basic mechanisms of fibrogenesis. A return to normal hepatic architecture from advanced fibrosis is achievable in some cases, and cirrhosis itself may be partly remediable.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17162224     DOI: 10.1016/j.cld.2006.08.022

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  20 in total

1.  Holeuryhalinity and its mechanisms in a cirriped crustacean, Balanus improvisus.

Authors:  H J Fyhn
Journal:  Comp Biochem Physiol A Comp Physiol       Date:  1976-01

2.  Noninvasive Biomarkers of Liver Fibrosis: Clinical Applications and Future Directions.

Authors:  Daniel L Motola; Peter Caravan; Raymond T Chung; Bryan C Fuchs
Journal:  Curr Pathobiol Rep       Date:  2014-12-01

Review 3.  Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases.

Authors:  Thomas A Wynn
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

4.  Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice.

Authors:  Marie-Luise Berres; Rory R Koenen; Anna Rueland; Mirko Moreno Zaldivar; Daniel Heinrichs; Hacer Sahin; Petra Schmitz; Konrad L Streetz; Thomas Berg; Nikolaus Gassler; Ralf Weiskirchen; Amanda Proudfoot; Christian Weber; Christian Trautwein; Hermann E Wasmuth
Journal:  J Clin Invest       Date:  2010-10-18       Impact factor: 14.808

5.  Regression of allograft airway fibrosis: the role of MMP-dependent tissue remodeling in obliterative bronchiolitis after lung transplantation.

Authors:  Masaaki Sato; David M Hwang; Zehong Guan; Jonathan C Yeung; Masaki Anraku; Dirk Wagnetz; Shin Hirayama; Thomas K Waddell; Mingyao Liu; Shaf Keshavjee
Journal:  Am J Pathol       Date:  2011-07-16       Impact factor: 4.307

6.  3D molecular MR imaging of liver fibrosis and response to rapamycin therapy in a bile duct ligation rat model.

Authors:  Christian T Farrar; Danielle K DePeralta; Helen Day; Tyson A Rietz; Lan Wei; Gregory Y Lauwers; Boris Keil; Arun Subramaniam; Anthony J Sinskey; Kenneth K Tanabe; Bryan C Fuchs; Peter Caravan
Journal:  J Hepatol       Date:  2015-05-25       Impact factor: 25.083

Review 7.  Cellular mechanisms of tissue fibrosis. 1. Common and organ-specific mechanisms associated with tissue fibrosis.

Authors:  Michael Zeisberg; Raghu Kalluri
Journal:  Am J Physiol Cell Physiol       Date:  2012-12-19       Impact factor: 4.249

8.  Reversal of liver fibrosis.

Authors:  Mona H Ismail; Massimo Pinzani
Journal:  Saudi J Gastroenterol       Date:  2009-01       Impact factor: 2.485

Review 9.  Cellular and molecular mechanisms of fibrosis.

Authors:  T A Wynn
Journal:  J Pathol       Date:  2008-01       Impact factor: 7.996

10.  Vitamin D reduces the expression of collagen and key profibrotic factors by inducing an antifibrotic phenotype in mesenchymal multipotent cells.

Authors:  Jorge N Artaza; Keith C Norris
Journal:  J Endocrinol       Date:  2008-11-26       Impact factor: 4.286

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.